NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1

CUSIP: 64125CAD1

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Debt / NOTE 2.250% 5/1
Market price (% of par)
125.0%
Total 13F principal
$376,964,000
Principal change
-$19,870,000
Total reported market value
$472,462,995
Number of holders
46
Value change
-$26,751,236
Number of buys
14
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 64125CAD1?
CUSIP 64125CAD1 identifies 64125CAD1 - NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 as of Q4 2021

As of 31 Dec 2021, NEUROCRINE BIOSCIENCES INC - NOTE 2.250% 5/1 was held by 46 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $376,964,000 in principal (par value) of the bond. The largest 10 bondholders included FRANKLIN RESOURCES INC, TENOR CAPITAL MANAGEMENT Co., L.P., D. E. Shaw & Co., Inc., MACKAY SHIELDS LLC, WELLS FARGO & COMPANY/MN, CSS LLC/IL, Weiss Asset Management LP, Invesco Ltd., WOLVERINE ASSET MANAGEMENT LLC, and GOLDMAN SACHS GROUP INC. This page lists 46 institutional bondholders reporting positions for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.